
July 10, 2019
Koios Medical, Inc has received 510(k) clearance from the U.S. Food and Drug Administration for Koios DS (Decision Support) Breast 2.0, a new version of its machine learning based platform that assists physicians in the classification and diagnosis of breast cancer.
Read more →
Sign-up for the Weekly Newsletter from FDA Reporter.